Papers/PMID:41123035
Riboflavin supplements for blood pressure lowering in adults.
The Cochrane database of systematic reviews2025The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
riboflavin — no detected effect on adverse event occurrence (oral or enteral supplement)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The evidence suggests that riboflavin may result in little to no difference in adverse events (odds ratio (OR) 1.92, 95% CI 0.16 to 22.56; P = 0.60; 1 study, 54 participants; low‐certainty evidence;.”
Quoted verbatim from Riboflavin supplements for blood pressure lowering in adults.. - Study
- meta-analysis
- Participants
- 54
- Population
- Adults with a history of migraine, riboflavin 400 mg/day for 12 weeks versus placebo (Schoenen 1998); this was the only one of the four included RCTs that reported adverse-event data.
Effect 1.92 odds ratio, 95% CI 0.16 to 22.56
Riboflavin supplements for blood pressure lowering in adults.2025PMID:41123035Permalink